RBC Capital Upgrades Edwards Lifesciences, Sees $5B Market Opportunity
July 13, 2015 at 09:04 AM EDT
In a report published Monday, RBC Capital Markets analyst Glenn Novarro upgraded the rating on Edwards Lifesciences Corp (NYSE: EW) from ...